MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-14-2026
ICON Public Limited Company Total Inventories 2011-2026 | ICLR
Annual Total Inventories ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 2.3 M | 2.2 M | 2.4 M | 1.8 M | 1.7 M | 2.2 M | 3 M | 2.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3 M | 1.7 M | 2.3 M |
Quarterly Total Inventories ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.8 M | - | - | - | 4.8 M | - | - | - | 3.2 M | - | - | - | 2.3 M | - | - | - | 2.2 M | - | - | - | 2.4 M | - | - | - | 1.8 M | - | - | - | 1.7 M | - | - | - | 2.2 M | - | - | - | 3 M | - | - | - | 2.8 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.8 M | 1.7 M | 2.93 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Biomerica
BMRA
|
1.49 M | $ 2.13 | -2.74 % | $ 4.89 M |  USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 25.75 | 3.0 % | $ 715 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 195.6 | 0.17 % | $ 21.7 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
629 M | $ 65.94 | -1.51 % | $ 25.7 B | USA |
 |
Co-Diagnostics
CODX
|
1.66 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | $ 104.91 | - | $ 19.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Charles River Laboratories International
CRL
|
299 M | $ 158.0 | 2.86 % | $ 7.83 B | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
7.83 M | $ 1.46 | 26.96 % | $ 1.86 M | USA |
 |
Interpace Biosciences
IDXG
|
1.21 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
IDEXX Laboratories
IDXX
|
378 M | $ 578.51 | 0.22 % | $ 46.5 B | USA |
 |
Agilent Technologies
A
|
830 M | $ 112.02 | 0.65 % | $ 34.1 B | USA |
 |
Illumina
ILMN
|
547 M | $ 123.79 | -0.43 % | $ 19.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
4.32 M | $ 7.5 | -6.13 % | $ 29.9 M |  Israel |
 |
Guardant Health
GH
|
85.9 M | $ 84.9 | -0.33 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
279 M | - | - | $ 10.6 B |  Niderland |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 17.56 | 2.39 % | $ 936 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 75.73 | -0.92 % | $ 5.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 264.42 | 0.54 % | $ 22 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 239.07 | 2.87 % | $ 25.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.66 | 1.75 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.62 M | $ 3.48 | 0.87 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.1 | 1.76 % | $ 1.04 B | USA |
 |
Natera
NTRA
|
35.4 M | $ 200.09 | 2.46 % | $ 19.7 B | USA |
 |
OPKO Health
OPK
|
56.8 M | $ 1.15 | 2.68 % | $ 798 M | USA |
 |
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.39 | 4.51 % | $ 417 M | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |